1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Structural Heart Devices Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Advancement/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Structural Heart Devices Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product type
5.2.1.1. Heart Valve Devices
5.2.1.1.1. Transcatheter Heart Valves
5.2.1.1.2. Surgical Heart Valve
5.2.1.1.2.1. Tissue Heart Valves
5.2.1.1.2.2. Mechanical Heart Valve
5.2.1.1.3. Occuluders & Delivery Systems
5.2.1.1.4. Annuloplasty Rings
5.2.1.1.5. Accessories
5.2.1.1.6. Others
5.2.2. By Procedure
5.2.2.1. Replacement Procedures
5.2.2.1.1. TAVR Procedures
5.2.2.1.2. SAVR Procedures
5.2.2.2. Repair Procedures
5.2.2.2.1. Closure Procedures
5.2.2.2.2. Annuloplasty
5.2.2.2.3. Valvuloplasty
5.2.2.2.4. TMVR Procedures
5.2.2.2.5. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. The Asia Pacific
5.2.3.4. Latin America
5.2.3.5. The Middle East and Africa
6. North America Structural Heart Devices Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product type
6.2.2. By Procedure
6.2.3. By Country
6.2.3.1. United States
6.2.3.2. Canada
7. Europe Structural Heart Devices Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product type
7.2.2. By Procedure
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. United Kingdom
7.2.3.3. Italy
7.2.3.4. France
7.2.3.5. Spain
7.2.3.6. Rest of Europe
8. The Asia Pacific Structural Heart Devices Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product type
8.2.2. By Procedure
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. South Korea
8.2.3.5. Rest of Asia Pacific
9. Latin America Structural Heart Devices Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product type
9.2.2. By Procedure
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Mexico
9.2.3.3. Rest of Latin America
10. The Middle East & Africa Structural Heart Devices Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product type
10.2.2. By Procedure
10.2.3. By Country
1.1.1.1. Saudi Arabia
1.1.1.2. UAE
1.1.1.3. South Africa
1.1.1.4. Rest of Middle East & Africa
2. Competitive Landscape
2.1. List of Key Players and Their Offerings
2.2. Market Share Analysis, 2021
2.3. Competitive Benchmarking, By Operating Parameters
2.4. Key Strategic Development (Merger, Acquisition, Partnership.)
3. Supplier Analysis
4. Impact of Covid-19 on Global Structural Heart Devices Market Industry
5. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
5.1. Abbott Laboratories
5.2. Affluent Medical SA
5.3. Artivion Inc
5.4. AtriCure Inc
5.5. CORONEO Inc ,
5.6. Braile Biomedica
5.7. Boston Scientific Corporation
5.8. Getinge AB
5.9. Jc Medical Inc
5.10. Johnson and Johnson Inc,
5.11. Other Prominent Players
6. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable